Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 7/20 | 0.70 |
| ▸ | LMNA | P02545 | 6/20 | 0.70 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | MAPT | P10636 | 4/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.70 |
| ▸ | STS | P08842 | 4/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | PGR | P06401 | 3/20 | 0.70 |
| ▸ | AR | P10275 | 3/20 | 0.70 |
| ▸ | TSHR | P16473 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.70 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.70 |
| ▸ | SHBG | P04278 | 2/20 | 0.70 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.70 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11783196 | 0.97 | STS (0.69) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL17817385 | 0.96 | STS (0.67) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL11780732 | 0.96 | STS (0.67) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL11788270 | 0.96 | STS (0.67) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL5157957 | 0.93 | ESR1 (0.69) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL5158676 | 0.89 | ESR1 (0.72) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL13345142 | 0.89 | ESR1 (0.72) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL14395341 | 0.89 | ESR1 (0.72) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL11239527 | 0.87 | LMNA (0.66) | ESR1LMNAESR2KMT2AMAPT | |
| SCHEMBL7612623 | 0.86 | LMNA (0.70) | ESR1LMNAKMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-3946052-A | 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity | STANFORD RESEARCH INSTITUTE (US) | 1976-03-23 | — | — | US | claimed |
| EP-1405860-B1 | Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use | STANFORD RES INST INT (US) | 2007-02-14 | — | — | EP | disclosed |
| EP-1405860-A1 | Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use | SRI INTERNATIONAL (US) | 2004-04-07 | — | — | EP | disclosed |
| EP-0914165-A4 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | PHERIN PHARM INC (US) | 2004-01-21 | — | — | EP | disclosed |
| US-6437156-B1 | ANTIANXIETY; AFFECTS THE FUNCTION OF THE AUTONOMIC NERVOUS SYSTEM AND A VARIETY OF BEHAVIORAL OR PHYSIOLOGICAL ACTIONS; VOMEROPHERINS; PHEROMONES | PHERIN CORPORATION | 2002-08-20 | — | — | US | disclosed |
| US-6432938-B1 | NASAL ADMINISTERING A STEROID | PHERIN CORPORATION | 2002-08-13 | — | — | US | disclosed |
| US-6331534-B1 | ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN | PHERIN PHARMACEUTICALS, INC. | 2001-12-18 | — | — | US | disclosed |
| US-6117860-A | NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY | PHERIN PHARMACEUTICALS, INC. (US) | 2000-09-12 | — | — | US | disclosed |
| US-6057439-A | EPOXYSTEROIDS | PHERIN CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| US-6046186-A | ANTITUMOR AGENTS, ANTICARCINOGENIC AGENTS | SRI INTERNATIONAL (US) | 2000-04-04 | — | — | US | disclosed |
| WO-1999033858-A9 | ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE | STANFORD RES INST INT (US) | 1999-10-28 | — | — | WO | disclosed |
| EP-0948521-A1 | 19-NOR-CHOLANE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION | Pherin Pharmaceuticals, Inc. (US) | 1999-10-13 | — | — | EP | disclosed |
| US-5922699-A | AFFECTING CERTAIN CONSEQUENT BEHAVIOR AND PHYSIOLOGY, E.G., THE REDUCTION OF ANXIETY | PHERIN CORPORATION (US) | 1999-07-13 | — | — | US | disclosed |
| EP-0914165-A1 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | Pherin Pharmaceuticals, Inc. (US) | 1999-05-12 | — | — | EP | disclosed |
| WO-1998014194-A9 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF ANXIETY | — | 1998-08-27 | — | — | WO | disclosed |
| WO-1998003207-A9 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | — | 1998-05-22 | — | — | WO | disclosed |
| WO-1998014194-A1 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF ANXIETY | PHERIN PHARMACEUTICALS (US) | 1998-04-09 | — | — | WO | disclosed |
| WO-1998003207-A1 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF PMS AND ANXIETY | PHERIN PHARMACEUTICALS, INC. (US) | 1998-01-29 | — | — | WO | disclosed |
| US-3946052-A | 19-Norpregna- 1,3,5(10)-trien-3-ol and loweralkyl homologs thereof having postcoital antifertility activity | STANFORD RESEARCH INSTITUTE (US) | 1976-03-23 | — | — | US | disclosed |